Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 13, 2026
Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Key Takeaways

  • RCAT shares are falling approximately 13% in premarket trading on May 13, 2026, following the announcement of a $200 million stock offering that threatens significant shareholder dilution
  • The equity offering is the primary catalyst, unveiled before the market open and immediately pressuring the stock
  • A recent Q1 2026 earnings report (released May 7) added an overhang: revenue of $15.5 million missed the FactSet consensus estimate of $17.6 million, and EPS of -$0.22 badly missed the -$0.12 estimate
  • Despite record 849% year-over-year revenue growth driven by U.S. Army drone contracts, profitability and margin concerns remain front and center for investors
  • Shares had already closed Tuesday at $11.03, down nearly 2% on the day, suggesting the stock was under pressure even before the offering news broke
  • Traders are watching the size and pricing of the offering, any use-of-proceeds disclosures, and whether institutional demand is sufficient to absorb the new shares

Opening Summary

Red Cat Holdings (RCAT) is a Puerto Rico-based aerospace and defense company that designs and manufactures tactical drone systems — including its flagship Black Widow small unmanned aerial system (sUAS) — for the U.S. military, NATO allies, and government security agencies. Shares are tumbling roughly 13% in premarket trading on May 13, 2026, declining from Tuesday's closing price of $11.03 to approximately $9.60. The selloff is driven by the company's announcement of a $200 million stock offering, a capital raise that markets are pricing as a dilutive event for existing shareholders at a time when the stock's recent earnings report had already disappointed expectations.

$200 Million Stock Offering Triggers Dilution Selloff

The dominant catalyst for the sharp premarket decline is Red Cat's announcement of a $200 million equity offering, disclosed before Wednesday's opening bell. Stock offerings of this scale are routinely met with selling pressure because they increase the total share count outstanding, diluting the ownership percentage and earnings per share attributable to current investors. The size of the raise is especially notable given the company's current market capitalization, making the dilution particularly pronounced relative to its existing equity base. Investors are reacting by selling ahead of the pricing of the deal, a classic pattern in secondary offerings from smaller-cap growth companies in the defense technology space.

Earnings Miss Adds to the Bearish Backdrop

The offering announcement lands against an already uncertain earnings backdrop. On May 7, 2026, Red Cat reported Q1 fiscal 2026 results that showed $15.5 million in revenue — a record quarter and an extraordinary 849% jump year-over-year, fueled by scaled deliveries under the U.S. Army Short Range Reconnaissance (SRR) program — but still fell short of the FactSet consensus estimate of $17.6 million. The EPS miss was even more severe: the company posted a loss of $0.22 per share, compared to analyst expectations of a $0.10 loss, as operating expenses surged 152% to $29.3 million, driven by sharp increases in R&D, sales and marketing, and G&A costs. Free cash outflow of $31.9 million and a cash balance declining from $167.9 million to $131.9 million during the quarter also flagged burn rate concerns heading into the offering announcement.

Sector Momentum and Contract Win Context

Red Cat has been building an impressive contract portfolio. The company recently won a deal to deliver 173 Black Widow drone systems to Japan's Ministry of Defense, secured new orders from a NATO ally facilitated through the NATO Support and Procurement Agency, and completed the acquisition of swarm robotics firm Apium. These developments speak to strong demand for its defense drone platforms and alignment with the broader global defense spending supercycle. The drone sector has been a market darling on the back of escalating geopolitical tensions and increased government procurement budgets, with defense-focused peers posting outsized gains. However, the stock's ongoing net losses — net loss widened to $26.6 million in Q1 — and the now-confirmed capital raise suggest the growth is coming at a steep cost that the market is increasingly scrutinizing.

Market Context and Trading Activity

Premarket volume in RCAT has already surged significantly relative to its 30-day average premarket volume of approximately 394,000 shares, with over 379,000 shares having changed hands in early premarket hours — an elevated figure consistent with a major corporate event. The stock closed Tuesday at $11.03, itself off 1.96% from the prior session, indicating that selling pressure was building even before the offering news went public. The broader defense ETF space, including names like ITA, will be worth watching during the regular session to assess whether RCAT's move reflects company-specific concerns or a wider sector-level de-risking. The stock's year-to-date gain of approximately 39% heading into Wednesday's session means longer-term holders are still sitting on meaningful profits, which may accelerate selling as they lock in gains into the dilutive offering.

Trending AI Robots

For traders navigating high-volatility events like secondary offerings or earnings reactions in stocks such as RCAT, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers across multiple asset classes, timeframes, and strategies — but only the strongest performers based on current market dynamics are featured in this dedicated Trending section. Each bot is characterized by its traded symbols, risk profile, holding period, and transparent performance metrics, giving traders a clear basis for comparison. Whether you are managing short-term swing trades or seeking systematic exposure to defense and technology trends, exploring the Trending AI Robots page is a sound starting point for integrating data-driven automation into your strategy.

What Comes Next for RCAT

The immediate priority for investors will be the final pricing and terms of the $200 million offering, including the disclosed use of proceeds — whether it targets acquisitions, working capital, SRR program scale-up, or further M&A in the drone ecosystem. Red Cat's next quarterly earnings report is expected around August 24, 2026, where analysts will be watching whether revenue growth is accelerating toward the upper end of contract delivery schedules and whether operating leverage begins to materialize. Contract execution risk remains high: the SRR program has been the engine of growth, and any delivery delays — as seen in prior quarters — could reset investor expectations sharply. Analyst consensus remains constructive, with an average price target of $21.75 from four analysts, though that target will almost certainly be revised following the dilutive offering. Key risks include ongoing net losses, geopolitical disruptions to NATO procurement timelines, integration execution for recently acquired Apium, and competitive pressure from larger defense primes entering the tactical drone market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: RCAT

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RCAT sees MACD Histogram crosses below signal line

RCAT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 24, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In 36 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCAT as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

RCAT moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RCAT crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for RCAT entered a downward trend on September 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for RCAT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCAT advanced for three days, in 234 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.299) is normal, around the industry mean (6.263). P/E Ratio (0.000) is within average values for comparable stocks, (55.218). RCAT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.867). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.155).

The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.62B. The market cap for tickers in the group ranges from 4.49 to 1.99T. SPCX holds the highest valuation in this group at 1.99T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 1%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -6%. ELMT experienced the highest price growth at 21%, while MRLN experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 67
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
RCAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.